Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials
Amanda Jane Leach*, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Mark D. Chatfield, Deborah Lehmann, Michael Binks, Anne B. Chang, Jonathan Carapetis, Vicki Krause, Ross Andrews, Tom Snelling, Sue A. Skull, Paul V. Licciardi, Victor M. OguomaPeter Stanley Morris
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
9Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials'. Together they form a unique fingerprint.